Inflammatory Response Research

IRR is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders

Inflammatory Response Research, Inc. (“IRR”) is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. Our initial product is an oral combination of levocetirizine (Xyzal) and montelukast (Singulair) at specific dosing for the treatment of influenza. Parallel research is focused on an intravenous (IV) preparation for the treatment of traumatic brain injury and severe cases of influenza.